May 14, 2018

INTERVIEWS: Hardide Plc Strong Interim Results

Hardide Plc (LON:HDD) CEO Phillip Kirkham talks to DirectorsTalk about its results for the six-month period ended 31 March 2018. Phil talks us through the highlights, his views on a..

Q&A with Fox Marble Holdings PLC CEO Chris Gilbert (LON:FOX)

Fox Marble Holdings PLC (LON:FOX) Chief Executive Officer Chris Gilbert caught up with DirectorsTalk for an exclusive interview to discuss their preliminary results, progress in 2018 and what investors should..

Cambria Automobiles PLC Q&A with Zeus Capital (LON:CAMB)

Cambria Automobiles PLC (LON:CAMB) is the topic of conversation when Zeus Capital’s Head of Research Mike Allen caught up with DirectorsTalk for an exclusive interview   Q1: Cambria Automobiles released..

Hardide plc Delivers strong first half performance and confident for second

Hardide Plc (LON:HDD), the developer and provider of advanced surface coating technology, today announced its results for the six-month period ended 31 March 2018. Financial Highlights · Revenue up by..

Savannah Resources Plc Letters of No Objection Received from all Eight Ministries

Savannah Resources plc (LON:SAV), the AIM quoted resource development company, has today announced the issuance of letters of no objection from all eight Ministries for both the Mahab 4 and..

MTI Wireless Edge Limited EPS Doubles, Cash Flow Triples

MTI Wireless Edge Limited (LON:MWE), a market leader in the manufacture of flat panel antennas for fixed wireless broadband and a wireless irrigation solutions provider, today announced its unaudited results..

Oncimmune Holdings plc Launches EarlyCDT®-Liver Test in the US

Oncimmune Holdings plc (LON:ONC), a leading early cancer detection company developing and commercialising its proprietary EarlyCDT® liquid biopsy platform technology, today announced that it has completed development of its EarlyCDT®-Liver..

Allergy Therapeutics Publishes New Data Validating its Patented Adjuvant, Microcrystalline Tyrosine

Allergy Therapeutics Plc (LON:AGY), a leading, fully-integrated commercial biotechnology company specialising in allergy vaccines, today announces that new data from a study investigating immune responses produced by microcrystalline tyrosine (MCT®)-based..

SkinBioTherapeutics Plc Files new patent application

SkinBioTherapeutics plc (LON:SBTX), a life science company focused on skin health, announced today a new patent filing. The patent application is to cover the use of SkinBiotix® for increasing filaggrin..

Entertainment One Ltd Say ABC drop Designated Survivor

Entertainment One Ltd (LON:ETO) confirms that Designated Survivor will no longer feature on ABC past the present series and that the Group is in active discussions with other parties for..

Search

Funds

May 14, 2018

Search

Funds

May 14, 2018

FTSE 100

Funds